Articles related to AMYOTROPHIC LATERAL SCLEROSIS (ALS)

PrimeC lowered neuron-derived TDP-43 levels in a Phase 2b ALS trial, with earlier analyses reporting functional and survival signals requiring confirmation in a planned pivotal study.

“A 65% reduction in the risk of death and a statistically significant extension in median survival of over 14 months represent a clinically meaningful benefit of notable magnitude in ALS.” — Alon Ben-Noon, CEO, Neurosense Therapeutics

“When Eric Dane brings his firefighter character into living rooms across the country, it helps people understand not only how emotionally and physically devastating the disease is, but also the grace and strength that people living with ALS show every day.”

Recent studies suggest that ALS may begin to develop shortly after conception, taking years or decades before symptoms appear, highlighting the importance of early intervention and lifestyle modifications.

Understanding the potential impact of household chemical exposures on ALS risk underscores the importance of environmental assessments in neurological care.

Recent findings suggest a notable correlation between certain recreational activities and an increased risk of ALS in men, emphasizing the need for healthcare professionals to consider environmental and lifestyle factors in disease risk assessment and patient counseling.